Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

Clinical academia is on a steep decline globally. In the UK, a 6% reduction in the number of clinical academics since 2012 has been reported, with the number of senior lecturer level researchers ...

As income and wealth inequality continue to divide Americans into two distinct classes and levels of wealth, those who are ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

The project is starting with a $240,000 grant from Alumbra, a foundation established by billionaire Christy Walton ...

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.